More stories

  • in

    Firefly Aerospace kicks off first moon mission after SpaceX launch

    Firefly Aerospace’s “Blue Ghost” cargo lander launched from Florida early Wednesday morning on SpaceX’s Falcon 9 rocket.
    The space transportation company’s first moon mission comes as it looks to expand into the nascent, NASA-led market for lunar services.
    Blue Ghost is expected to make a landing attempt on March 2 and spend up to two weeks on the surface.

    The company’s Blue Ghost moon lander before shipping out for launch.
    Firefly Aerospace

    Another American company, Texas-based rocket and spacecraft builder Firefly Aerospace, is moon-bound.
    Firefly’s “Blue Ghost” cargo lander launched from Florida early Wednesday morning on SpaceX’s Falcon 9 rocket to begin a 45-day trip.

    The space transportation company’s first moon mission comes as it looks to expand into the nascent, NASA-led market for lunar services.
    “We’re now fully focused on execution as we look to complete our on-orbit operations, softly touch down on the lunar surface, and pave the way for humanity’s return to the Moon,” Firefly CEO Jason Kim said in a statement after the launch.
    Firefly is best known for its Alpha rockets, which launch satellites into orbit. But the company in recent years expanded into building lunar landers and space tugs.

    Read more CNBC space news

    The nearly 7-foot-tall lander, named Blue Ghost after a rare firefly species in the U.S., is carrying 10 government and commercial payloads under a $101 million NASA contract.
    Firefly’s “Ghost Riders in the Sky” mission is the third under NASA’s Commercial Lunar Payload Services program. CLPS aims to deliver science projects and cargo to the moon with increasing regularity in support of the agency’s Artemis crew program. Two other companies, Astrobotic and Intuitive Machines, each launched missions last year – the former’s fell short while the latter’s tipped on its side but survived the landing.

    Blue Ghost stacked inside the rocket’s nosecone in preparation for launch.

    Firefly outlined 17 milestones it hopes to achieve with Blue Ghost, with landing one of the final steps. So far, the company confirmed the mission has achieved five of those milestones, including the stages of launch and testing the spacecraft in orbit.
    The mission is expected to land on March 2 and is targeting the lunar basin Mare Crisium on the moon’s near side. After touching down, Firefly aims to operate the lander for a full lunar day — which equates to about 14 days on Earth — as well as operate for several hours into the lunar night.

    A rendering that depicts the Blue Ghost lander on the moon’s surface.
    Firefly Aerospace

    Notably, SpaceX’s rocket carried not just one, but two lunar landers on Wednesday morning’s launch.
    Japanese company ispace is flying its second moon mission after its first crash-landed in 2023. While Firefly was the primary payload for the launch, ispace had previously booked a “rideshare” agreement with SpaceX, meaning its lander would end up hitching a ride.
    And more moon attempts are on the way this year. NASA expects as many as five U.S. companies to launch lunar landing missions this year in 2025. More

  • in

    JPMorgan Chase tops estimates on better-than-expected interest income, Wall Street results

    JPMorgan Chase on Wednesday topped estimates for fourth-quarter revenue and profit.
    The bank was helped by better-than-expected net interest income and fixed income trading and investment banking results.
    Profit rose 50% to $14 billion in the quarter as noninterest expenses fell 7% from a year earlier.

    JPMorgan Chase on Wednesday topped estimates for fourth-quarter revenue and profit, helped by better-than-expected net interest income and fixed income trading and investment banking results.
    Here’s what the company reported:

    Earnings: $4.81 a share vs. $4.11 LSEG estimate
    Revenue: $43.74 billion vs. $41.73 billion expected

    The bank said profit rose 50% to $14 billion in the quarter as noninterest expenses fell 7% from a year earlier, when the firm had a $2.9 billion FDIC assessment tied to regional bank failures.
    Revenue climbed 10% to $43.74 billion, helped by Wall Street operations and better-than-expected net interest income of $23.47 billion, exceeding the StreetAccount estimate by roughly $400 million.
    Fixed income trading revenue jumped 20% to $5 billion, topping the $4.42 billion StreetAcount estimate on rising credit and currency results. Equities revenue climbed 22% to $2 billion, missing the $2.37 billion estimate.
    Investment banking fees jumped 49% to $2.48 billion, topping the $2.39 billion estimate.
    CEO Jamie Dimon said in the release that the economy was “resilient,” buoyed by low unemployment and healthy consumer spending, as well as optimism for the Trump administration’s pro-growth agenda.

    “However, two significant risks remain,” Dimon said. “Ongoing and future spending requirements will likely be inflationary, and therefore, inflation may persist for some time. Additionally, geopolitical conditions remain the most dangerous and complicated since World War II. As always, we hope for the best but prepare the firm for a wide range of scenarios.”
    Banks ended the year with several reasons to be bullish: Wall Street activity has picked up at the same time that Main Street consumers remain resilient, while the election victory of Donald Trump has led to hopes of regulatory relief.
    While the business is thriving, analysts will likely ask Dimon about his succession planning after his No. 2 executive, Daniel Pinto, said he was stepping down as chief operating officer in June. Dimon signaled last year that he was likely to step down as CEO within five years.
    Another question is how the changing outlook for Federal Reserve rate cuts will impact the bank across its sweeping operations. While Fed officials expect two more cuts this year, economic indicators could cause them to pause.
    Finally, analysts may press JPMorgan on what it intends to do with a possible windfall of capital if Trump regulators present a gentler version of the Basel 3 Endgame, as potential nominees have supported. Dimon said last May that share buybacks would be muted because the stock was expensive, but they’ve only climbed since.
    Besides JPMorgan, Goldman Sachs, Wells Fargo and Citigroup are also out with quarterly and full-year results Wednesday, while Bank of America and Morgan Stanley are due to report on Thursday.
    This story is developing. Please check back for updates. More

  • in

    Citigroup swings to fourth-quarter profit, tops estimates on investment banking strength

    Jane Fraser speaks during the Milken Institute Global Conference in Beverly Hills, California, U.S., on Monday, April 29, 2019.
    Kyle Grillot | Bloomberg via Getty Images

    Citigroup reported its fourth-quarter earnings Wednesday morning ahead of Wall Street’s opening bell, beating estimates on the top and bottom lines.
    Shares of the bank rose more than 2% in premarket trading.

    Here is how the company did relative to LSEG analyst consensus estimates:

    Earnings: $1.34 a share, vs $1.22 expected
    Revenue: $19.58 billion, vs $19.49 billion expected

    Citi’s net income was $2.86 billion from the quarter, an improvement from a net loss of $1.84 billion a year ago. Year-over-year comparisons for fourth quarter income metrics may be complicated by charges Citi booked in the final period of 2023.
    The bank reported growth across several different business units during the fourth quarter. Markets revenue jumped 36% year over year, with both the fixed income and equity businesses growing. Revenue for the wealth and services unites climbed 20% and 15%, respectively, year over year.
    Banking revenue grew 12%, and that expanded to 27% when including the impact of loan hedges.
    “2024 was a critical year and our results show our strategy is delivering as intended and driving stronger performance in our businesses. Our net income was up nearly 40% to $12.7 billion and we exceeded our full-year revenue target, including record years in Services, Wealth and U.S. Personal Banking,” CEO Jane Fraser said in a press release.

    On the analyst call later Wednesday, investors will also be looking for progress updates about Fraser’s turnaround efforts. Fraser took over the bank in March 2021 and has focused on slimming down the company, including selling off some international units.
    Citi’s stock was a strong performer in 2024, rising nearly 37% on the year. The stock was up more than 4% so far this year entering Wednesday. More

  • in

    Wells Fargo shares jump after earnings beat, strong 2025 guidance

    Wells Fargo shares climbed Wednesday after the bank posted better-than-expected earnings and issued strong guidance on net interest income for 2025.
    Here’s what the bank reported for the fourth quarter compared with what Wall Street was expecting, based on a survey of analysts by LSEG:

    Adjusted earnings per share: $1.42 vs. $1.35 expected
    Revenue: $20.38 billion versus $20.59 billion expected

    Net income of $5.1 billion, or $1.43 per diluted common share, came in 47% higher than the figure from the fourth quarter in the year prior.
    The San Francisco-based lender said it expects 2025 net interest income, a key measure of what a bank makes on loans, to be 1% to 3% higher than 2024’s number of $47.7 billion.
    Shares of Wells jumped 3% in premarket trading Wednesday following the release of earnings.
    “Our solid performance this quarter caps a year of significant progress for Wells Fargo,” CEO Charlie Scharf said in a statement. “Our earnings profile continues to improve, we are seeing the benefit from investments we are making to increase our growth and improve how we serve our customers and communities, we maintained a strong balance sheet, we returned approximately $25 billion of capital to shareholders, and we made significant progress on our risk and control work.”
    Wells Fargo’s investment banking fees jumped 59% to $725 million in the fourth quarter compared with a year earlier.

    The bank repurchased 57.8 million shares, or $4.0 billion, of common stock in fourth quarter 2024.
    Shares of the bank surged nearly 43% in 2024, and the stock is up 1.4% so far in January.

    Don’t miss these insights from CNBC PRO More

  • in

    Disney wins the 2024 box office as year-end receipts offer a welcome boost

    The combination of Disney and Marvel’s “Deadpool & Wolverine,” Pixar’s “Inside Out 2,” Disney Animation’s “Moana 2” and Universal’s “Wicked” boosted the box office during the final months of 2024.
    Full-year ticket sales were down just 3.4% from 2023, reaching $8.74 billion, a far cry from the nearly 27% shortage seen at the midway point of 2024.
    Disney collected the most ticket sales for the year, representing 25% of the total domestic market.

    Ryan Reynolds and Hugh Jackman star in Marvel’s “Deadpool & Wolverine.”

    Foul-mouthed superheroes and family-friendly fare propped up the domestic box office during the final months of 2024.
    Full-year ticket sales were down just 3.4% from 2023, reaching $8.74 billion, a far cry from the nearly 27% shortage seen at the midway point of 2024.

    The combination of Disney and Marvel’s “Deadpool & Wolverine,” Pixar’s “Inside Out 2,” Disney Animation’s “Moana 2” and Universal’s “Wicked,” all of which were released after June, buoyed ticket sales and turned a billion-dollar deficit into just $300 million, according to data from Comscore.
    “While 2024 was one of the most challenging ever for theatres, the massive comeback that began in June due to the residual impact of the strikes and resultant production delays that threw the release slate into disarray in the early part of the year is nothing short of remarkable,” said Paul Dergarabedian, senior media analyst at Comscore.
    Box-office analysts had predicted the 2024 box office would lag significantly behind the $9 billion tallied in 2023. After all, the production calendar was disrupted by dual Hollywood labor strikes the year prior, postponing major blockbuster releases into the second half of 2024. Some were even delayed until 2025 and 2026.

    “Expectations entering the year were saddled with the weight of release delays caused by industry strikes, on top of the ongoing adjustment to modern consumer habits that have taken hold in a world of shorter theatrical windows and increased demand for state-of-the-art experiences inside cinemas themselves,” said Shawn Robbins, director of analytics at Fandango and founder of Box Office Theory.
    The first-half ticket sales slump was a disappointment after the box office had seen steady annual growth in the wake of the pandemic. However, industry analysts foresee a rebound in 2025 and the potential to break the $10 billion mark in 2026.

    The next two years are stacked with blockbuster franchises and films tied to popular, existing intellectual property. And while there has been some worry that the industry had become too inundated with licensed material, particularly in the superhero genre, 2024 has proven that audiences will still come out in droves for these films.
    In fact, all of the top 10 highest-grossing films of 2024 were from major film franchises or tied to popular IP. And that’s a good sign, considering 2025 and 2026 are set to be packed with big titles.
    “The year will see a resumption of a franchise-heavy-driven lineup,” wrote Eric Handler, managing director at Roth MKM, in a recent research note. “Vying for the highest-grossing movies of the year should be ‘Avatar: Fire and Ash,’ ‘Jurassic World: Rebirth’ and ‘Wicked: For Good,’ all of which should be able to surpass $400 [million].”

    Disney magic

    Disney, in particular, benefited from franchise films in 2024. The company is responsible for three of the four top-grossing films of the year — Pixar’s “Inside Out 2,” Marvel’s “Deadpool & Wolverine” and Disney Animation’s “Moana 2.”
    “Inside Out 2” jump-started the box office, taking in more than $650 million domestically and becoming the first film since Warner Bros.′ “Barbie” to top $1 billion at the global box office.
    This was an import win for Disney’s Pixar animation hub. A once prolifically successful studio, Pixar has suffered at the box office in the wake of the pandemic. Much of its difficulties have come, in part, because Disney opted to debut a handful of animated features directly on streaming service Disney+ during theatrical closures and even once cinemas had reopened.
    As a result, prior to “Inside Out 2,” no Disney animated feature from Pixar or its Walt Disney Animation studio had generated more than $480 million at the global box office since 2019. “Inside Out 2” ultimately became the highest-grossing film of 2024.
    The second-highest was Disney’s first-ever R-rated Marvel feature. “Deadpool & Wolverine” hit theaters in July and quickly earned the record for the highest debut of an R-rated film ever. It went on to top $1 billion at the global box office, the only R-rated film other than Warner Bros.’ “Joker” to do so, and also became the highest-grossing R-rated film of all time.
    “Deadpool & Wolverine” brought a much-needed boost to the Marvel Cinematic Universe, which has struggled with consistency at the box office in the wake of the record-shattering “Avengers: Endgame” in 2019.
    Handler said the superhero genre is seeking “a bit of redemption,” noting that Marvel has three major releases in 2025: “Captain America: Brave New World,” “Thunderbolts*” and “The Fantastic Four: First Steps.”
    Warner Bros. will also debut its first film under James Gunn and Peter Safran, its new heads of the DC Studio. All eyes will be on “Superman: Legacy,” especially after the woeful box office of “Joker: Folie a Deux.”
    Disney also had “Moana 2,” the fourth-highest-grossing film of the year. It arrived at Thanksgiving, shattering the record for the highest-opening film during that five-day holiday period with $221 million in domestic ticket sales. It went on to snag $404 million domestically and over $900 million globally.
    Together, these films alongside other theatrical releases helped Disney reach more than $2.2 billion at the domestic box office last year, accounting for about 25% of the industry’s total haul.

    Universal, fueled by “Wicked,” “Despicable Me 4,” “Twisters” and “Kung Fu Panda 4” represented 21.6% of the total market share with $1.8 billion in box-office receipts for the year. “Wicked” was the third-highest-grossing film of 2024, collecting $432 million domestically and breaking the curse of movie musicals at the box office. It also became the highest debut of a Broadway adaptation in cinematic history.
    Warner Bros. tallied $1.19 billion, or 13.7% market share. Sony snared $1 billion, or 11.5%, and Paramount rounded out the top five with $880 million, or 10%.
    “The late year ’24 moviegoing rally has set up a solid 2025 for movie theatres,” Dergarabedian said. “[G]iven the more stable calendar with a more orderly cadence, frequency and importantly a greater number of wide release films … the resultant momentum will virtually guarantee even bigger results for theatrical exhibition this year.”
    Disclosure: Comcast is the parent company of NBCUniversal and CNBC. NBCUniversal is the distributor of “Wicked,” “Despicable Me 4,” “Twisters” and “Kung Fu Panda 4,” and the owner of Fandango. More

  • in

    Goldman Sachs tops estimates on strong trading results

    Here’s what the company reported: Earnings of $11.95 a share vs. $8.22 LSEG estimate
    Revenue: $13.87 billion vs. $12.39 billion expected

    David Solomon, Chairman & CEO Goldman Sachs, speaking on CNBC’s Squawk Box at the World Economic Forum Annual Meeting in Davos, Switzerland on Jan. 17th, 2024.
    Adam Galici | CNBC

    Goldman Sachs on Wednesday posted fourth-quarter results that topped estimates on stronger than expected trading revenue.
    Here’s what the company reported:

    Earnings: $11.95 a share vs. $8.22 LSEG estimate
    Revenue: $13.87 billion vs. $12.39 billion expected

    The bank said profit roughly doubled from a year earlier to $4.11 billion, or $11.95 a share, as revenues grew while expenses shrank. Revenue jumped 23% to $13.87 billion, helped by higher equities and fixed income trading revenue, and rising investment banking results.
    Equities trading generated $3.45 billion in revenue, roughly $450 million more than the StreetAccount estimate. Fixed income trading made $2.74 billion in revenue, topping the estimate by almost $300 million. Investment banking fees of $2.05 billion essentially matched the estimate.
    Another source of strength for the bank was its asset and wealth management division, which saw revenue jump 8% to $4.72 billion, topping estimates by $560 million.
    “With an improving operating backdrop and growing CEO confidence, we are harnessing the power of One Goldman Sachs to continue to serve our clients with excellence and create further value for our shareholders,” CEO David Solomon said in the release.
    Goldman Sachs is riding a wave of enthusiasm over a rebound in Wall Street deals.

    The bank’s shares jumped nearly 50% last year, topping its big bank rivals, as the Federal Reserve’s easing cycle and the November election of Donald Trump boosted expectations for mergers and stock deals.
    For Solomon, the setup couldn’t be more different than a year earlier, in the aftermath of a strategic pivot away from an ill-fated foray into consumer finance.
    Back then, Solomon was under pressure to appease internal stakeholders including Goldman partners as losses tied to consumer finance mounted, and as Wall Street deals dried up because of rising rates and heightened regulatory scrutiny.
    JPMorgan Chase is also reporting results Wednesday, along with Wells Fargo and Citigroup, while Bank of America and Morgan Stanley are due to report on Thursday.
    This story is developing. Please check back for updates. More

  • in

    Mark Wiedman, a top BlackRock exec thought to be Fink’s successor, is leaving the company

    Mark Wiedman, head of BlackRock’s global client business, attends the Global Financial Leaders’ Investment Summit, in Hong Kong, Nov. 8, 2023.
    Tyrone Siu | Reuters

    Mark Wiedman, a senior BlackRock executive with a tenure that spans more than 20 years, is leaving the asset manager, according to a person familiar with the matter.
    Wiedman, head of the global client business for the past two years, was believed to be a potential successor to Chief Executive Larry Fink.

    Wiedman was instrumental in driving BlackRock’s growth in passive investing. From 2011 to 2019, he led BlackRock’s exchange-traded and index strategies while assets under management in the business increased from $500 billion to $1.7 trillion.
    He joined BlackRock in 2004 to oversee the firm’s emergency assistance to governments and financial institutions during the financial crisis.
    BlackRock is the world’s largest asset manager with assets under management hitting a record $11.5 trillion in the fourth quarter. The firm made two big acquisitions last year in a push to expand in private credit and alternatives. In December, the financial firm agreed to buy HPS Investment Partners for $12 billion in stock, as BlackRock looks to grow its presence in the highly popular private credit space. BlackRock also acquired Global Infrastructure Partners, an infrastructure investor, for $12.5 billion last year.

    Don’t miss these insights from CNBC PRO More

  • in

    Eli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand

    Eli Lilly cut its 2024 revenue guidance, saying demand for its obesity and diabetes drugs had not met its lofty expectations.
    Eli Lilly expects about $3.5 billion in revenue for its diabetes treatment Mounjaro and $1.9 billion for its obesity drug Zepbound.
    CEO Dave Ricks told CNBC that the company has “tons of supply coming online” and that it will add more manufacturing capacity.

    The Eli Lilly & Co. logo at the company’s Digital Health Innovation Hub facility in Singapore, on Thursday, Nov. 14, 2024. 
    Ore Huiying | Bloomberg | Getty Images

    Eli Lilly cut its revenue guidance on Tuesday as it said demand for its weight loss and diabetes drugs would not meet its lofty expectations.
    The drugmaker’s shares closed more than 6% lower on Tuesday.

    Eli Lilly said it now expects full-year 2024 revenue of about $45 billion. That’s lower than the $45.4 billion to $46 billion the company anticipated in October. The new outlook would still mark a 32% jump in revenue from the prior year.
    Eli Lilly has been racing to meet soaring demand for its diabetes treatment Mounjaro and obesity drug Zepbound, investing billions to ramp up its manufacturing capacity of the company’s booming so-called incretin drugs. The efforts appear to be paying off: The Food and Drug Administration in December reaffirmed its decision to declare the U.S. shortage of tirzepatide — the active ingredient in both drugs — over.
    In an interview with CNBC on Tuesday, Eli Lilly CEO Dave Ricks said the company has “tons of supply coming online” and “that kind of growth will likely continue.”
    He also noted that the company will add more manufacturing capacity and expects to produce at least 60% more sellable doses of its incretin drugs in the first half of the year compared with the same period in 2024.

    More CNBC health coverage

    For the fourth quarter, Eli Lilly expects $13.5 billion in revenue. The total includes about $3.5 billion for Mounjaro and $1.9 billion for Zepbound.

    Wall Street had expected fourth-quarter and full-year revenue of $13.94 billion and $45.49 billion, respectively, according to analysts surveyed by LSEG.
    The outlook cut comes as Eli Lilly competes with Novo Nordisk and other, smaller rivals for share of the exploding weight loss and diabetes drug market. Eli Lilly is developing an obesity pill that would be more convenient for patients and easier to manufacture, and Ricks expects it to be approved as soon as early next year.
    “While the U.S. incretin market grew 45% compared to the same quarter last year, our previous guidance had anticipated even faster acceleration of growth for the quarter. That, in addition to lower-than-expected channel inventory at year-end, contributed to our Q4 results,” Ricks said in a statement.
    The drugmaker also said it expects sales of $58 billion to $61 billion in fiscal 2025.
    Eli Lilly is expected to report full quarterly results on Feb. 6.

    Don’t miss these insights from CNBC PRO More